Investment Analysts’ price target changes for Wednesday, November 6th:
AbbVie (NYSE:ABBV) had its price target boosted by Guggenheim from $212.00 to $221.00. They currently have a buy rating on the stock.
Air Canada (TSE:AC) had its price target boosted by TD Cowen to C$25.00. TD Cowen currently has a buy rating on the stock.
Arcellx (NASDAQ:ACLX) had its target price boosted by Morgan Stanley from $81.00 to $106.00. The firm currently has an overweight rating on the stock.
Arcellx (NASDAQ:ACLX) had its price target raised by Bank of America Co. from $84.00 to $100.00. Bank of America Co. currently has a buy rating on the stock.
Arcellx (NASDAQ:ACLX) had its target price boosted by Robert W. Baird from $77.00 to $106.00. Robert W. Baird currently has an outperform rating on the stock.
Arcellx (NASDAQ:ACLX) had its target price boosted by HC Wainwright from $80.00 to $95.00. The firm currently has a buy rating on the stock.
Addus HomeCare (NASDAQ:ADUS) had its price target trimmed by Royal Bank of Canada from $141.00 to $136.00. They currently have an outperform rating on the stock.
AGCO (NYSE:AGCO) had its price target trimmed by Oppenheimer Holdings Inc. from $131.00 to $111.00. The firm currently has an outperform rating on the stock.
AGCO (NYSE:AGCO) had its price target reduced by The Goldman Sachs Group, Inc. from $112.00 to $99.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
AdaptHealth (NASDAQ:AHCO) had its target price reduced by Canaccord Genuity Group Inc. from $14.00 to $13.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
AdaptHealth (NASDAQ:AHCO) had its price target trimmed by Robert W. Baird from $16.00 to $14.00. They currently have an outperform rating on the stock.
American International Group (NYSE:AIG) had its price target trimmed by Wells Fargo & Company from $77.00 to $76.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Allstate (NYSE:ALL) had its price target boosted by Keefe, Bruyette & Woods from $222.00 to $225.00. The firm currently has an outperform rating on the stock.
American Homes 4 Rent (NYSE:AMH) had its price target lowered by Keefe, Bruyette & Woods from $39.00 to $38.00. They currently have a market perform rating on the stock.
Alpha and Omega Semiconductor (NASDAQ:AOSL) had its price target reduced by Stifel Nicolaus from $34.00 to $27.00. The firm currently has a sell rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its price target lowered by The Goldman Sachs Group, Inc. from $71.00 to $36.00. The firm currently has a buy rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its price target reduced by Piper Sandler from $40.00 to $32.00. The firm currently has a neutral rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its price target trimmed by Wells Fargo & Company from $43.00 to $30.00. The firm currently has an equal weight rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its price target reduced by Scotiabank from $35.00 to $30.00. Scotiabank currently has a sector perform rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its target price lowered by Bank of America Co. from $61.00 to $47.00. Bank of America Co. currently has a buy rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its price target reduced by HC Wainwright from $83.00 to $57.00. HC Wainwright currently has a buy rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its price target cut by Oppenheimer Holdings Inc. from $65.00 to $40.00. They currently have an outperform rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its target price lowered by Needham & Company LLC from $85.00 to $60.00. Needham & Company LLC currently has a buy rating on the stock.
Apollo Global Management (NYSE:APO) had its target price boosted by Barclays PLC from $148.00 to $174.00. They currently have an overweight rating on the stock.
Apollo Global Management (NYSE:APO) had its price target raised by BMO Capital Markets from $138.00 to $157.00. They currently have an outperform rating on the stock.
Apollo Global Management (NYSE:APO) had its price target increased by Deutsche Bank Aktiengesellschaft from $141.00 to $155.00. The firm currently has a buy rating on the stock.
Apollo Global Management (NYSE:APO) had its price target increased by Wells Fargo & Company from $149.00 to $164.00. The firm currently has an overweight rating on the stock.
Apollo Global Management (NYSE:APO) had its price target increased by Keefe, Bruyette & Woods from $159.00 to $168.00. The firm currently has an outperform rating on the stock.
Apollo Global Management (NYSE:APO) had its target price increased by Evercore ISI from $150.00 to $174.00. They currently have an outperform rating on the stock.
Apollo Global Management (NYSE:APO) had its price target increased by TD Cowen from $165.00 to $178.00. TD Cowen currently has a buy rating on the stock.
Aris Water Solutions (NYSE:ARIS) had its target price raised by Evercore ISI from $20.00 to $25.00. Evercore ISI currently has an outperform rating on the stock.
Aris Water Solutions (NYSE:ARIS) had its target price raised by Stifel Nicolaus from $20.00 to $26.00. Stifel Nicolaus currently has a buy rating on the stock.
Aris Water Solutions (NYSE:ARIS) had its target price raised by The Goldman Sachs Group, Inc. from $18.50 to $21.00. They currently have a buy rating on the stock.
AvalonBay Communities (NYSE:AVB) had its target price lowered by Royal Bank of Canada from $234.00 to $233.00. They currently have a sector perform rating on the stock.
Aviat Networks (NASDAQ:AVNW) had its target price cut by Roth Mkm from $43.00 to $39.00. The firm currently has a buy rating on the stock.
AXIS Capital (NYSE:AXS) had its price target boosted by Keefe, Bruyette & Woods from $94.00 to $96.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Bath & Body Works (NYSE:BBWI) had its target price trimmed by Wells Fargo & Company from $35.00 to $32.00. They currently have an equal weight rating on the stock.
Beam Therapeutics (NASDAQ:BEAM) had its price target cut by Royal Bank of Canada from $27.00 to $24.00. Royal Bank of Canada currently has a sector perform rating on the stock.
B&G Foods (NYSE:BGS) had its target price lowered by Evercore ISI from $10.00 to $9.00. Evercore ISI currently has an in-line rating on the stock.
B&G Foods (NYSE:BGS) had its price target reduced by TD Cowen from $8.00 to $7.50. The firm currently has a sell rating on the stock.
TopBuild (NYSE:BLD) had its target price lowered by Evercore ISI from $491.00 to $443.00. The firm currently has an outperform rating on the stock.
Ballard Power Systems (NASDAQ:BLDP) (TSE:BLD) had its price target trimmed by CIBC from $1.60 to $1.40. They currently have an underperformer rating on the stock.
Builders FirstSource (NYSE:BLDR) had its target price raised by Royal Bank of Canada from $178.00 to $187.00. They currently have an outperform rating on the stock.
Bowhead Specialty (NYSE:BOW) had its price target raised by Royal Bank of Canada from $32.00 to $35.00. They currently have an outperform rating on the stock.
Broadridge Financial Solutions (NYSE:BR) had its price target increased by Morgan Stanley from $200.00 to $207.00. The firm currently has an equal weight rating on the stock.
BellRing Brands (NYSE:BRBR) had its price target increased by Barclays PLC from $68.00 to $74.00. Barclays PLC currently has an overweight rating on the stock.
Bruker (NASDAQ:BRKR) had its price target cut by Barclays PLC from $75.00 to $69.00. The firm currently has an overweight rating on the stock.
Bruker (NASDAQ:BRKR) had its target price trimmed by Wells Fargo & Company from $78.00 to $75.00. Wells Fargo & Company currently has an overweight rating on the stock.
Bruker (NASDAQ:BRKR) had its target price reduced by TD Cowen from $72.00 to $70.00. They currently have a hold rating on the stock.
Bioventus (NYSE:BVS) had its target price raised by Canaccord Genuity Group Inc. from $12.00 to $15.00. They currently have a buy rating on the stock.
BWX Technologies (NYSE:BWXT) had its target price increased by Deutsche Bank Aktiengesellschaft from $129.00 to $130.00. They currently have a buy rating on the stock.
Maplebear (NASDAQ:CART) had its target price increased by Oppenheimer Holdings Inc. from $48.00 to $55.00. Oppenheimer Holdings Inc. currently has an outperform rating on the stock.
Casey’s General Stores (NASDAQ:CASY) had its target price increased by Deutsche Bank Aktiengesellschaft from $451.00 to $454.00. They currently have a buy rating on the stock.
Chemours (NYSE:CC) had its price target cut by Royal Bank of Canada from $28.00 to $25.00. Royal Bank of Canada currently has an outperform rating on the stock.
Coca-Cola Europacific Partners (NASDAQ:CCEP) had its price target raised by Evercore ISI from $78.00 to $82.00. They currently have an outperform rating on the stock.
ChromaDex (NASDAQ:CDXC) had its target price boosted by Roth Mkm from $6.00 to $8.00. They currently have a buy rating on the stock.
Celanese (NYSE:CE) had its target price lowered by Barclays PLC from $151.00 to $101.00. Barclays PLC currently has an equal weight rating on the stock.
Celanese (NYSE:CE) had its price target trimmed by Morgan Stanley from $140.00 to $100.00. The firm currently has an equal weight rating on the stock.
Celanese (NYSE:CE) had its price target trimmed by Robert W. Baird from $150.00 to $110.00. Robert W. Baird currently has an outperform rating on the stock.
Choice Hotels International (NYSE:CHH) had its price target boosted by Robert W. Baird from $138.00 to $145.00. They currently have an outperform rating on the stock.
Colliers International Group (NASDAQ:CIGI) (TSE:CIGI) had its price target increased by Scotiabank from $155.00 to $167.50. Scotiabank currently has a sector outperform rating on the stock.
Cummins (NYSE:CMI) had its price target boosted by Robert W. Baird from $330.00 to $372.00. They currently have a neutral rating on the stock.
Cummins (NYSE:CMI) had its target price raised by The Goldman Sachs Group, Inc. from $324.00 to $370.00. The firm currently has a neutral rating on the stock.
Cricut (NASDAQ:CRCT) had its price target reduced by The Goldman Sachs Group, Inc. from $6.50 to $5.75. The firm currently has a neutral rating on the stock.
CRISPR Therapeutics (NASDAQ:CRSP) had its price target trimmed by Barclays PLC from $59.00 to $55.00. Barclays PLC currently has an equal weight rating on the stock.
Castle Biosciences (NASDAQ:CSTL) had its target price increased by Scotiabank from $37.00 to $44.00. The firm currently has a sector outperform rating on the stock.
Endava (NYSE:DAVA) had its price target trimmed by Guggenheim from $45.00 to $40.00. They currently have a buy rating on the stock.
DuPont de Nemours (NYSE:DD) had its price target increased by Wells Fargo & Company from $105.00 to $107.00. The firm currently has an overweight rating on the stock.
DuPont de Nemours (NYSE:DD) had its price target raised by Barclays PLC from $84.00 to $85.00. They currently have an underweight rating on the stock.
Distribution Solutions Group (NASDAQ:DSGR) had its target price increased by Barrington Research from $43.00 to $44.00. They currently have an outperform rating on the stock.
Eastman Chemical (NYSE:EMN) had its price target reduced by Royal Bank of Canada from $107.00 to $105.00. Royal Bank of Canada currently has a sector perform rating on the stock.
Emerson Electric (NYSE:EMR) had its price target lowered by Royal Bank of Canada from $139.00 to $138.00. The firm currently has an outperform rating on the stock.
Emerson Electric (NYSE:EMR) had its price target raised by Barclays PLC from $103.00 to $116.00. They currently have an equal weight rating on the stock.
Emerson Electric (NYSE:EMR) had its target price increased by Wells Fargo & Company from $128.00 to $135.00. The firm currently has an overweight rating on the stock.
Emerson Electric (NYSE:EMR) had its price target raised by KeyCorp from $125.00 to $140.00. KeyCorp currently has an overweight rating on the stock.
Emerson Electric (NYSE:EMR) had its price target boosted by Deutsche Bank Aktiengesellschaft from $136.00 to $140.00. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.
Exact Sciences (NASDAQ:EXAS) had its target price trimmed by Craig Hallum from $82.00 to $65.00. The firm currently has a buy rating on the stock.
Exact Sciences (NASDAQ:EXAS) had its price target lowered by Robert W. Baird from $70.00 to $67.00. Robert W. Baird currently has an outperform rating on the stock.
Exact Sciences (NASDAQ:EXAS) had its price target lowered by Benchmark Co. from $67.00 to $65.00. The firm currently has a buy rating on the stock.
Exact Sciences (NASDAQ:EXAS) had its price target cut by The Goldman Sachs Group, Inc. from $75.00 to $65.00. They currently have a buy rating on the stock.
Exact Sciences (NASDAQ:EXAS) had its price target reduced by TD Cowen from $90.00 to $82.00. The firm currently has a buy rating on the stock.
Exact Sciences (NASDAQ:EXAS) had its price target lowered by Evercore ISI from $80.00 to $60.00. They currently have an outperform rating on the stock.
Exact Sciences (NASDAQ:EXAS) had its target price reduced by BTIG Research from $82.00 to $65.00. BTIG Research currently has a buy rating on the stock.
Exact Sciences (NASDAQ:EXAS) had its target price trimmed by Stifel Nicolaus from $82.00 to $67.00. They currently have a buy rating on the stock.
Exact Sciences (NASDAQ:EXAS) had its target price lowered by Canaccord Genuity Group Inc. from $95.00 to $75.00. They currently have a buy rating on the stock.
Endeavour Silver (NYSE:EXK) (TSE:EDR) had its target price boosted by HC Wainwright from $6.00 to $7.25. HC Wainwright currently has a buy rating on the stock.
Expeditors International of Washington (NASDAQ:EXPD) had its target price raised by TD Cowen from $106.00 to $108.00. They currently have a sell rating on the stock.
Expeditors International of Washington (NASDAQ:EXPD) had its target price boosted by Barclays PLC from $105.00 to $110.00. Barclays PLC currently has an underweight rating on the stock.
Freshpet (NASDAQ:FRPT) had its target price raised by Stifel Nicolaus from $155.00 to $165.00. Stifel Nicolaus currently has a buy rating on the stock.
GAP (NYSE:GAP) had its target price cut by Wells Fargo & Company from $32.00 to $28.00. They currently have an overweight rating on the stock.
GlobalFoundries (NASDAQ:GFS) had its price target cut by Susquehanna from $50.00 to $48.00. They currently have a neutral rating on the stock.
GlobalFoundries (NASDAQ:GFS) had its price target cut by Deutsche Bank Aktiengesellschaft from $55.00 to $50.00. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.
GlobalFoundries (NASDAQ:GFS) had its price target reduced by Robert W. Baird from $63.00 to $50.00. The firm currently has an outperform rating on the stock.
GlobalFoundries (NASDAQ:GFS) had its price target trimmed by Evercore ISI from $71.00 to $55.00. The firm currently has an outperform rating on the stock.
Globus Medical (NYSE:GMED) had its price target raised by Stifel Nicolaus from $80.00 to $92.00. They currently have a buy rating on the stock.
Globus Medical (NYSE:GMED) had its price target boosted by Royal Bank of Canada from $80.00 to $92.00. They currently have an outperform rating on the stock.
Globus Medical (NYSE:GMED) had its target price boosted by Canaccord Genuity Group Inc. from $79.00 to $85.00. The firm currently has a buy rating on the stock.
Globus Medical (NYSE:GMED) had its price target increased by Bank of America Co. from $55.00 to $80.00. Bank of America Co. currently has an underperform rating on the stock.
Globus Medical (NYSE:GMED) had its price target boosted by Wells Fargo & Company from $78.00 to $88.00. The firm currently has an overweight rating on the stock.
Globus Medical (NYSE:GMED) had its price target boosted by Piper Sandler from $80.00 to $100.00. Piper Sandler currently has an overweight rating on the stock.
Grocery Outlet (NASDAQ:GO) had its price target trimmed by Wells Fargo & Company from $26.00 to $23.00. Wells Fargo & Company currently has an overweight rating on the stock.
Grocery Outlet (NASDAQ:GO) had its price target lowered by Deutsche Bank Aktiengesellschaft from $29.00 to $26.00. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.
Grocery Outlet (NASDAQ:GO) had its target price cut by Craig Hallum from $20.00 to $17.00. The firm currently has a hold rating on the stock.
Grocery Outlet (NASDAQ:GO) had its price target trimmed by Roth Mkm from $20.00 to $16.00. Roth Mkm currently has a neutral rating on the stock.
Grocery Outlet (NASDAQ:GO) had its price target cut by Telsey Advisory Group from $19.00 to $18.00. They currently have a market perform rating on the stock.
Grindr (NYSE:GRND) had its price target increased by TD Cowen from $14.00 to $17.00. The firm currently has a buy rating on the stock.
GXO Logistics (NYSE:GXO) had its price target increased by TD Cowen from $82.00 to $83.00. They currently have a buy rating on the stock.
HCA Healthcare (NYSE:HCA) had its price target boosted by Wells Fargo & Company from $395.00 to $400.00. The firm currently has an equal weight rating on the stock.
Home Depot (NYSE:HD) had its target price raised by Wells Fargo & Company from $400.00 to $430.00. They currently have an overweight rating on the stock.
Hims & Hers Health (NYSE:HIMS) had its price target boosted by Deutsche Bank Aktiengesellschaft from $23.00 to $27.00. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock.
Hillman Solutions (NASDAQ:HLMN) had its target price increased by Barclays PLC from $10.00 to $12.00. Barclays PLC currently has an equal weight rating on the stock.
Hillman Solutions (NASDAQ:HLMN) had its price target increased by Robert W. Baird from $12.00 to $14.00. Robert W. Baird currently has an outperform rating on the stock.
Horace Mann Educators (NYSE:HMN) had its price target boosted by Piper Sandler from $36.00 to $42.00. Piper Sandler currently has a neutral rating on the stock.
Huntsman (NYSE:HUN) had its target price trimmed by Wells Fargo & Company from $26.00 to $25.00. The firm currently has an overweight rating on the stock.
Hyster-Yale Materials Handling (NYSE:HY) had its target price cut by Roth Mkm from $84.00 to $70.00. They currently have a buy rating on the stock.
Illumina (NASDAQ:ILMN) had its price target increased by Robert W. Baird from $124.00 to $139.00. Robert W. Baird currently has a neutral rating on the stock.
Ingredion (NYSE:INGR) had its price target increased by Oppenheimer Holdings Inc. from $147.00 to $178.00. Oppenheimer Holdings Inc. currently has an outperform rating on the stock.
Ingredion (NYSE:INGR) had its price target raised by BMO Capital Markets from $128.00 to $147.00. The firm currently has a market perform rating on the stock.
Ingredion (NYSE:INGR) had its price target increased by Barclays PLC from $145.00 to $168.00. Barclays PLC currently has an overweight rating on the stock.
Invitation Homes (NYSE:INVH) had its price target cut by Keefe, Bruyette & Woods from $37.00 to $35.00. They currently have a market perform rating on the stock.
Century Therapeutics (NASDAQ:IPSC) had its target price cut by HC Wainwright from $9.00 to $5.00. They currently have a buy rating on the stock.
Gartner (NYSE:IT) had its target price increased by Robert W. Baird from $565.00 to $590.00. Robert W. Baird currently has an outperform rating on the stock.
Gartner (NYSE:IT) had its target price boosted by Barclays PLC from $470.00 to $525.00. The firm currently has an equal weight rating on the stock.
Gartner (NYSE:IT) had its price target raised by Deutsche Bank Aktiengesellschaft from $529.00 to $531.00. The firm currently has a hold rating on the stock.
Gartner (NYSE:IT) had its target price increased by Wells Fargo & Company from $460.00 to $470.00. They currently have an underweight rating on the stock.
Itron (NASDAQ:ITRI) had its target price raised by Guggenheim from $128.00 to $135.00. Guggenheim currently has a buy rating on the stock.
JELD-WEN (NYSE:JELD) had its target price reduced by Royal Bank of Canada from $13.00 to $9.00. The firm currently has an underperform rating on the stock.
JELD-WEN (NYSE:JELD) had its target price trimmed by The Goldman Sachs Group, Inc. from $17.00 to $10.00. The firm currently has a neutral rating on the stock.
JELD-WEN (NYSE:JELD) had its target price cut by Barclays PLC from $13.00 to $10.00. The firm currently has an equal weight rating on the stock.
Karyopharm Therapeutics (NASDAQ:KPTI) had its target price increased by Piper Sandler from $4.00 to $5.00. They currently have an overweight rating on the stock.
Kymera Therapeutics (NASDAQ:KYMR) had its target price raised by Morgan Stanley from $45.00 to $49.00. They currently have an equal weight rating on the stock.
Lindblad Expeditions (NASDAQ:LIND) had its price target boosted by Craig Hallum from $12.00 to $16.00. They currently have a buy rating on the stock.
Alliant Energy (NASDAQ:LNT) had its price target reduced by Barclays PLC from $61.00 to $59.00. Barclays PLC currently has an equal weight rating on the stock.
Lowe’s Companies (NYSE:LOW) had its target price boosted by Wells Fargo & Company from $280.00 to $295.00. Wells Fargo & Company currently has an overweight rating on the stock.
Louisiana-Pacific (NYSE:LPX) had its price target boosted by The Goldman Sachs Group, Inc. from $90.00 to $99.00. The firm currently has a sell rating on the stock.
Louisiana-Pacific (NYSE:LPX) had its target price increased by Royal Bank of Canada from $119.00 to $125.00. They currently have an outperform rating on the stock.
Lululemon Athletica (NASDAQ:LULU) had its target price raised by Robert W. Baird from $350.00 to $380.00. They currently have an outperform rating on the stock.
Lumen Technologies (NYSE:LUMN) had its target price raised by The Goldman Sachs Group, Inc. from $4.50 to $5.00. They currently have a neutral rating on the stock.
Lumen Technologies (NYSE:LUMN) had its target price trimmed by TD Cowen from $7.00 to $6.00. TD Cowen currently has a hold rating on the stock.
Masimo (NASDAQ:MASI) had its price target boosted by Piper Sandler from $165.00 to $180.00. Piper Sandler currently has an overweight rating on the stock.
Masimo (NASDAQ:MASI) had its price target raised by Wells Fargo & Company from $160.00 to $171.00. The firm currently has an overweight rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its target price reduced by Susquehanna from $95.00 to $90.00. Susquehanna currently has a positive rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its price target trimmed by Piper Sandler from $100.00 to $85.00. The firm currently has an overweight rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its price target cut by TD Cowen from $80.00 to $70.00. TD Cowen currently has a hold rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its target price reduced by Needham & Company LLC from $96.00 to $85.00. The firm currently has a buy rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its target price reduced by KeyCorp from $100.00 to $95.00. The firm currently has an overweight rating on the stock.
Altria Group (NYSE:MO) had its target price boosted by Barclays PLC from $45.00 to $46.00. The firm currently has an underweight rating on the stock.
Marathon Petroleum (NYSE:MPC) had its price target trimmed by TD Cowen from $174.00 to $170.00. TD Cowen currently has a buy rating on the stock.
Marqeta (NASDAQ:MQ) had its price target lowered by The Goldman Sachs Group, Inc. from $5.50 to $4.50. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
MGIC Investment (NYSE:MTG) had its target price cut by Royal Bank of Canada from $28.00 to $27.00. They currently have a sector perform rating on the stock.
Northern Dynasty Minerals (NYSEAMERICAN:NAK) (TSE:NDM) had its target price increased by HC Wainwright from $0.80 to $1.30. The firm currently has a buy rating on the stock.
National CineMedia (NASDAQ:NCMI) had its price target increased by Barrington Research from $7.50 to $8.25. They currently have an outperform rating on the stock.
Novanta (NASDAQ:NOVT) had its price target cut by Robert W. Baird from $175.00 to $169.00. The firm currently has a neutral rating on the stock.
National Storage Affiliates Trust (NYSE:NSA) had its price target boosted by Robert W. Baird from $39.00 to $42.00. Robert W. Baird currently has a neutral rating on the stock.
NXP Semiconductors (NASDAQ:NXPI) had its target price reduced by Needham & Company LLC from $300.00 to $250.00. Needham & Company LLC currently has a buy rating on the stock.
NXP Semiconductors (NASDAQ:NXPI) had its price target cut by Morgan Stanley from $250.00 to $235.00. The firm currently has an equal weight rating on the stock.
NXP Semiconductors (NASDAQ:NXPI) had its price target cut by Oppenheimer Holdings Inc. from $330.00 to $300.00. The firm currently has an outperform rating on the stock.
NXP Semiconductors (NASDAQ:NXPI) had its price target trimmed by Truist Financial Co. from $287.00 to $252.00. They currently have a buy rating on the stock.
NXP Semiconductors (NASDAQ:NXPI) had its price target trimmed by Susquehanna from $260.00 to $250.00. They currently have a neutral rating on the stock.
NXP Semiconductors (NASDAQ:NXPI) had its target price cut by Evercore ISI from $370.00 to $315.00. They currently have an outperform rating on the stock.
Realty Income (NYSE:O) had its price target cut by Royal Bank of Canada from $67.00 to $63.00. The firm currently has an outperform rating on the stock.
ONE Gas (NYSE:OGS) had its price target lowered by Wells Fargo & Company from $82.00 to $81.00. Wells Fargo & Company currently has an overweight rating on the stock.
ON (NYSE:ONON) had its target price raised by Telsey Advisory Group from $47.00 to $53.00. They currently have an outperform rating on the stock.
Offerpad Solutions (NYSE:OPAD) had its target price lowered by Keefe, Bruyette & Woods from $3.75 to $3.15. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Payoneer Global (NASDAQ:PAYO) had its price target increased by Keefe, Bruyette & Woods from $9.00 to $12.00. They currently have an outperform rating on the stock.
Payoneer Global (NASDAQ:PAYO) had its target price boosted by Needham & Company LLC from $10.00 to $14.00. Needham & Company LLC currently has a buy rating on the stock.
Payoneer Global (NASDAQ:PAYO) had its price target boosted by Benchmark Co. from $10.00 to $12.00. Benchmark Co. currently has a buy rating on the stock.
Payoneer Global (NASDAQ:PAYO) had its price target increased by The Goldman Sachs Group, Inc. from $9.00 to $12.00. They currently have a buy rating on the stock.
Progressive (NYSE:PGR) had its target price increased by Evercore ISI from $277.00 to $285.00. Evercore ISI currently has an outperform rating on the stock.
Premier (NASDAQ:PINC) had its price target increased by Canaccord Genuity Group Inc. from $19.00 to $21.00. They currently have a hold rating on the stock.
Premier (NASDAQ:PINC) had its price target raised by Barclays PLC from $20.00 to $24.00. They currently have an equal weight rating on the stock.
Premier (NASDAQ:PINC) had its price target raised by Robert W. Baird from $19.00 to $20.00. The firm currently has a neutral rating on the stock.
Primoris Services (NASDAQ:PRIM) had its target price increased by The Goldman Sachs Group, Inc. from $51.00 to $78.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
Qualys (NASDAQ:QLYS) had its target price increased by Royal Bank of Canada from $150.00 to $162.00. Royal Bank of Canada currently has a sector perform rating on the stock.
Qualys (NASDAQ:QLYS) had its target price raised by Canaccord Genuity Group Inc. from $160.00 to $170.00. The firm currently has a buy rating on the stock.
Qualys (NASDAQ:QLYS) had its target price increased by Morgan Stanley from $123.00 to $126.00. Morgan Stanley currently has an underweight rating on the stock.
Qualys (NASDAQ:QLYS) had its price target boosted by TD Cowen from $130.00 to $150.00. TD Cowen currently has a hold rating on the stock.
Qualys (NASDAQ:QLYS) had its price target raised by Truist Financial Co. from $120.00 to $145.00. Truist Financial Co. currently has a hold rating on the stock.
Restaurant Brands International (NYSE:QSR) (TSE:QSR) had its target price reduced by Royal Bank of Canada from $95.00 to $90.00. The firm currently has an outperform rating on the stock.
Restaurant Brands International (NYSE:QSR) (TSE:QSR) had its target price trimmed by KeyCorp from $80.00 to $78.00. They currently have an overweight rating on the stock.
Restaurant Brands International (NYSE:QSR) (TSE:QSR) had its price target cut by CIBC from $88.00 to $86.00. The firm currently has an outperformer rating on the stock.
Restaurant Brands International (NYSE:QSR) (TSE:QSR) had its target price lowered by Evercore ISI from $93.00 to $90.00. The firm currently has an outperform rating on the stock.
uniQure (NASDAQ:QURE) had its target price trimmed by Royal Bank of Canada from $16.00 to $14.00. The firm currently has an outperform rating on the stock.
uniQure (NASDAQ:QURE) had its target price lowered by The Goldman Sachs Group, Inc. from $10.00 to $9.00. They currently have a neutral rating on the stock.
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target increased by Canaccord Genuity Group Inc. from $109.00 to $121.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its target price increased by HC Wainwright from $82.00 to $95.00. HC Wainwright currently has a buy rating on the stock.
Dr. Reddy’s Laboratories (NYSE:RDY) had its target price lowered by Barclays PLC from $17.40 to $17.00. The firm currently has an overweight rating on the stock.
Regeneron Pharmaceuticals (NASDAQ:REGN) had its target price reduced by Oppenheimer Holdings Inc. from $1,150.00 to $1,000.00. They currently have an outperform rating on the stock.
Regal Rexnord (NYSE:RRX) had its price target lowered by Robert W. Baird from $223.00 to $208.00. Robert W. Baird currently has an outperform rating on the stock.
Revolve Group (NYSE:RVLV) had its price target increased by Robert W. Baird from $24.00 to $33.00. The firm currently has a neutral rating on the stock.
Revolve Group (NYSE:RVLV) had its price target increased by Piper Sandler from $30.00 to $35.00. They currently have an overweight rating on the stock.
Revolve Group (NYSE:RVLV) had its price target raised by BTIG Research from $30.00 to $35.00. BTIG Research currently has a buy rating on the stock.
Revolve Group (NYSE:RVLV) had its target price raised by TD Cowen from $28.00 to $34.00. The firm currently has a buy rating on the stock.
Revolve Group (NYSE:RVLV) had its target price increased by Evercore ISI from $21.00 to $33.00. They currently have an in-line rating on the stock.
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its price target increased by Canaccord Genuity Group Inc. from $77.00 to $80.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its target price raised by TD Cowen from $55.00 to $65.00. TD Cowen currently has a buy rating on the stock.
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its price target increased by Needham & Company LLC from $55.00 to $64.00. They currently have a buy rating on the stock.
Solaris Energy Infrastructure (NASDAQ:SEI) had its target price raised by Stifel Nicolaus from $15.00 to $23.00. They currently have a buy rating on the stock.
Super Micro Computer (NASDAQ:SMCI) had its price target trimmed by The Goldman Sachs Group, Inc. from $67.50 to $28.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
Syndax Pharmaceuticals (NASDAQ:SNDX) had its target price raised by HC Wainwright from $45.00 to $47.00. They currently have a buy rating on the stock.
Spotify Technology (NYSE:SPOT) had its price target raised by Deutsche Bank Aktiengesellschaft from $430.00 to $440.00. They currently have a buy rating on the stock.
Sensata Technologies (NYSE:ST) had its target price lowered by TD Cowen from $50.00 to $45.00. They currently have a buy rating on the stock.
Latham Group (NASDAQ:SWIM) had its price target increased by The Goldman Sachs Group, Inc. from $3.00 to $5.00. The Goldman Sachs Group, Inc. currently has a sell rating on the stock.
Latham Group (NASDAQ:SWIM) had its price target boosted by Robert W. Baird from $5.50 to $7.50. They currently have an outperform rating on the stock.
Tenet Healthcare (NYSE:THC) had its target price increased by Wells Fargo & Company from $195.00 to $205.00. Wells Fargo & Company currently has an overweight rating on the stock.
Timken (NYSE:TKR) had its target price trimmed by KeyCorp from $104.00 to $90.00. KeyCorp currently has an overweight rating on the stock.
Timken (NYSE:TKR) had its price target trimmed by Oppenheimer Holdings Inc. from $102.00 to $97.00. The firm currently has an outperform rating on the stock.
Treace Medical Concepts (NASDAQ:TMCI) had its price target raised by Stifel Nicolaus from $7.00 to $8.00. Stifel Nicolaus currently has a hold rating on the stock.
TPG (NASDAQ:TPG) had its price target reduced by TD Cowen from $62.00 to $58.00. They currently have a hold rating on the stock.
Entrada Therapeutics (NASDAQ:TRDA) had its target price boosted by Oppenheimer Holdings Inc. from $25.00 to $28.00. They currently have an outperform rating on the stock.
Entrada Therapeutics (NASDAQ:TRDA) had its price target boosted by HC Wainwright from $18.00 to $20.00. They currently have a buy rating on the stock.
Targa Resources (NYSE:TRGP) had its price target raised by Wells Fargo & Company from $153.00 to $190.00. Wells Fargo & Company currently has an overweight rating on the stock.
Thomson Reuters (NYSE:TRI) (TSE:TRI) had its price target raised by Scotiabank from $182.00 to $187.00. The firm currently has a sector outperform rating on the stock.
Thomson Reuters (NYSE:TRI) (TSE:TRI) had its price target boosted by Royal Bank of Canada from $171.00 to $173.00. The firm currently has a sector perform rating on the stock.
Universal Health Services (NYSE:UHS) had its price target raised by Wells Fargo & Company from $275.00 to $285.00. Wells Fargo & Company currently has an overweight rating on the stock.
UL Solutions (NYSE:ULS) had its target price raised by Wells Fargo & Company from $56.00 to $62.00. The firm currently has an overweight rating on the stock.
UL Solutions (NYSE:ULS) had its price target boosted by Robert W. Baird from $53.00 to $57.00. The firm currently has a neutral rating on the stock.
UL Solutions (NYSE:ULS) had its target price raised by The Goldman Sachs Group, Inc. from $45.00 to $51.00. They currently have a neutral rating on the stock.
Verve Therapeutics (NASDAQ:VERV) had its target price boosted by Canaccord Genuity Group Inc. from $29.00 to $32.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Verve Therapeutics (NASDAQ:VERV) had its price target lowered by Royal Bank of Canada from $20.00 to $17.00. They currently have an outperform rating on the stock.
Verve Therapeutics (NASDAQ:VERV) had its target price lowered by HC Wainwright from $15.00 to $14.00. HC Wainwright currently has a buy rating on the stock.
Vornado Realty Trust (NYSE:VNO) had its price target increased by Evercore ISI from $40.00 to $45.00. They currently have an outperform rating on the stock.
Vornado Realty Trust (NYSE:VNO) had its price target increased by Compass Point from $32.00 to $40.00. The firm currently has a neutral rating on the stock.
Viper Energy (NASDAQ:VNOM) had its target price increased by Truist Financial Co. from $57.00 to $64.00. The firm currently has a buy rating on the stock.
Vertex Pharmaceuticals (NASDAQ:VRTX) had its target price boosted by Canaccord Genuity Group Inc. from $361.00 to $408.00. Canaccord Genuity Group Inc. currently has a sell rating on the stock.
Westlake (NYSE:WLK) had its target price trimmed by Wells Fargo & Company from $180.00 to $160.00. Wells Fargo & Company currently has an overweight rating on the stock.
Essential Utilities (NYSE:WTRG) had its price target increased by Robert W. Baird from $45.00 to $46.00. They currently have an outperform rating on the stock.
Xometry (NASDAQ:XMTR) had its target price increased by Craig Hallum from $20.00 to $30.00. The firm currently has a buy rating on the stock.
Xometry (NASDAQ:XMTR) had its target price boosted by Royal Bank of Canada from $23.00 to $27.00. They currently have a sector perform rating on the stock.
Xometry (NASDAQ:XMTR) had its target price raised by The Goldman Sachs Group, Inc. from $24.00 to $28.00. The Goldman Sachs Group, Inc. currently has a buy rating on the stock.
Xylem (NYSE:XYL) had its price target lowered by TD Cowen from $138.00 to $125.00. TD Cowen currently has a hold rating on the stock.
Yum! Brands (NYSE:YUM) had its target price reduced by Deutsche Bank Aktiengesellschaft from $147.00 to $145.00. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock.
Receive News & Ratings for AbbVie Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbbVie Inc and related companies with MarketBeat.com's FREE daily email newsletter.
